AccelerOnc Studio

🚀 “This venture studio strengthens our ability to bring Moffitt’s expertise & innovations to cancer patients around the world.” – Patrick Hwu, M.D., President & CEO @MoffittNews With @AccelerOnc Studio, we’re entering a new era where AI & digital tech transform cancer care.

🚀 Introducing AccelerOnc Studio—the nation’s first venture studio solely dedicated to cancer innovation, founded by @MoffittNews Cancer Center. Learn more: acceleronc.com/news_events #AccelerOnc #InnovationToImpact

Today we’re celebrating the launch of @AccelerOnc, the first U.S. venture studio focused solely on oncology innovation and founded by Moffitt. By merging data, expertise and urgency, we’re driving bold ideas forward to prevent and cure cancer. #InnovationToImpact

More than a venture builder, AccelerOnc is a strategic enabler of Moffitt’s mission to prevent & cure cancer—creating early-stage companies rooted in real-world patient & clinical needs. Together, we’re shaping the future of oncology. #AccelerOnc #InnovationToImpact #CancerCare

Our focus spans the next frontier of cancer care: 🔹 Digital Health 🔹 Artificial Intelligence 🔹 Data-driven platforms Each designed to accelerate the path from innovation → impact.

Cancer is becoming more complex. Care is becoming more data-driven @AccelerOnc provides a bold new way to bridge the gap between discovery & impact—turning world-class research & clinical expertise into companies that deliver real solutions for patients acceleronc.com/news_events

🚀 Big news for #OncologyInnovation We’re proud to launch @AccelerOnc - the nation’s first venture studio solely dedicated to cancer innovation—founded by @MoffittNews 📖 Learn more: acceleronc.com/news_events #AccelerOnc #InnovationToImpact #CancerCare